US20020058592A1 - Delivery system for cyclopropenes - Google Patents

Delivery system for cyclopropenes Download PDF

Info

Publication number
US20020058592A1
US20020058592A1 US09/950,967 US95096701A US2002058592A1 US 20020058592 A1 US20020058592 A1 US 20020058592A1 US 95096701 A US95096701 A US 95096701A US 2002058592 A1 US2002058592 A1 US 2002058592A1
Authority
US
United States
Prior art keywords
composition
cyclopropene
cyclodextrin
molecular encapsulation
methylcyclopropene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/950,967
Other versions
US6444619B1 (en
Inventor
Edward Kostansek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AgroFresh Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/950,967 priority Critical patent/US6444619B1/en
Publication of US20020058592A1 publication Critical patent/US20020058592A1/en
Assigned to ROHM AND HAAS COMPANY reassignment ROHM AND HAAS COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KOSTANSEK, EDWARD CHARLES
Application granted granted Critical
Publication of US6444619B1 publication Critical patent/US6444619B1/en
Assigned to AGROFRESH INC reassignment AGROFRESH INC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DOW AGROSCIENCES LLC, DOW GLOBAL TECHNOLOGIES LLC, ROHM AND HAAS COMPANY
Assigned to BANK OF MONTREAL, AS ADMINISTRATIVE AGENT reassignment BANK OF MONTREAL, AS ADMINISTRATIVE AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AGROFRESH INC.
Assigned to BANK OF MONTREAL, AS COLLATERAL AGENT reassignment BANK OF MONTREAL, AS COLLATERAL AGENT PATENT SECURITY AGREEMENT Assignors: AGROFRESH, INC.
Anticipated expiration legal-status Critical
Assigned to AGROFRESH, INC. reassignment AGROFRESH, INC. TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 036243, FRAME 0244 Assignors: BANK OF MONTREAL
Assigned to AGROFRESH, INC. reassignment AGROFRESH, INC. TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 053316, FRAME 0561 Assignors: BANK OF MONTREAL
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N3/00Preservation of plants or parts thereof, e.g. inhibiting evaporation, improvement of the appearance of leaves or protection against physical influences such as UV radiation using chemical compositions; Grafting wax
    • A01N3/02Keeping cut flowers fresh chemically
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N27/00Biocides, pest repellants or attractants, or plant growth regulators containing hydrocarbons

Definitions

  • the present invention relates to complexes formed from molecular encapsulation agents such as cyclodextrin, and cyclopropene and its derivatives such as methylcyclopropene, which are capable of inhibiting the ethylene response in plants.
  • Such complexes provide a convenient means for storing and transporting these compounds which are reactive gases and highly unstable because of oxidation and other potential reactions.
  • Such complexes also provide convenient methods of delivering to plants these compounds in order to extend their shelf life.
  • 6,017,849 discloses a method of incorporating these gaseous compounds into a molecular encapsulation agent complex in order to stabilize their reactivity and thereby provide a convenient and safe means of storing, transporting and applying or delivering the active compounds to plants.
  • the preferred molecular encapsulation agent is a cyclodextrin with a-cyclodextrin being the most preferred.
  • the application or delivery of these active compounds is then accomplished by simply adding water to the molecular encapsulation agent complex.
  • the complex prepared according to the methods disclosed in U.S. Pat. No. 6,017,849 provides the material in the form of a powder.
  • Powder formulations suffer from a number of deficiencies including, for example, dustiness, difficulty in measuring small amounts (which may require that the material be prepackaged), and difficulty in controlling the release of the encapsulated material from the powder.
  • the 1-methylcyclopropene/ ⁇ -cyclodextrin complex noted above releases the 1-methylcyclopropene very quickly. It would be advantageous to moderate the release of 1-methylcyclopropene so that very little of it is released during the first few minutes after the complex is added to water. This would help prevent the escape of the 1-methylcyclopropene from the treatment area before it can be sealed and, consequently, improve the efficacy of the treatment.
  • the present invention is, therefore, a composition comprising:
  • R is hydrogen or a substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, phenyl, or naphthyl group; wherein the substituents are independently halogen, alkoxy, or substituted or unsubstituted phenoxy;
  • composition is pressure agglomerated.
  • alkyl means both straight and branched chain (C 1 -C 20 ) radicals which include, for example, methyl, ethyl, n-propyl, isopropyl, 1-ethylpropyl, n-butyl, tert-butyl, isobutyl, 2,2-dimethylpropyl, pentyl, octyl, and decyl.
  • alkenyl and “alkynyl” mean (C 3 -C 20 )alkenyl and (C 3 -C 20 )alkynyl groups such as, for example, 2-propenyl, 2-butenyl, 3-butenyl, 2-methyl-2-propenyl, and 2-propynyl.
  • cycloalkylalkyl means a (C 1 -C 15 ) alkyl group substituted with a (C 3 -C 6 ) cycloalkyl group such as, for example cyclopropylmethyl, cyclopropylethyl, cyclobutylmethyl, and cyclopentylethyl.
  • haloalkyl means an alkyl radical wherein one or more of the hydrogen atoms have been replaced by a halogen atom.
  • halogen means fluorine, chlorine, bromine, and iodine.
  • R is (C 1 -C 10 ) alkyl. More preferably, R is (C 1 -C 8 ) alkyl. Even more preferably R is (C 1 -C 4 ) alkyl. Most preferably, R is methyl.
  • Preferred encapsulating agents include cyclodextrins, crown ethers, polyoxyalkylenes, polysiloxanes, and zeolites. More preferred encapsulating agents include ⁇ -cyclodextrin, ⁇ -cyclodextrin, and ⁇ -cyclodextrin. The most preferred encapsulating agent, particularly when the cyclopropene is 1-methylcyclopropene, is ⁇ -cyclodextrin. The most preferred encapsulting agent will vary depending upon the size of the R substituent.
  • Cyclodextrins are available from Wacker Biochem Inc., Adrian, Mich. or Cerestar USA, Hammond, Ind., as well as other vendors.
  • the cyclopropenes applicable to this invention are known materials prepared using the processes disclosed in U.S. Pat. Nos. 5,518,988 and 6,017,849.
  • the cyclopropene/molecular encapsulation agent complexes of the present invention are prepared by contacting the cyclopropene with a solution or slurry of the molecular encapsulation agent and then isolating the complex, again using general processes disclosed in U.S. Pat. No. 6,017,849.
  • adjuvants such as, for example, binders, lubricants, release agents, surfactants and/or dispersants, wetting agents, spreading agents, dispersing agents, stickers, adhesives, defoamers, thickeners, and emulsifying agents.
  • adjuvants commonly used in the art can be found in the John W. McCutcheon, Inc. publication Detergents and Emulsifiers, Annual, Allured Publishing Company, Ridgewood, N.J., U.S.A.
  • One or more of such adjuvants may be added to the composition prior to agglomeration or as a coating onto the agglomerated material.
  • adjuvants may be added to the composition at the time the cyclopropene is released as an aid to the releasing process.
  • Preferred adjuvants include; a) binders such as, for example, sucrose, dextrose, dextrins, and other sugars and starches, polymers such as polyvinyl alcohol and lignosulfonates, and inorganics such as clays and salts, b) lubricants such as, for example, talc, magnesium stearate, stearic acid, graphite, and waxes, and c) release agents such as surfactants including, for example, sodium dodecyl sulfate.
  • binders such as, for example, sucrose, dextrose, dextrins, and other sugars and starches, polymers such as polyvinyl alcohol and lignosulfonates, and inorganics such as clays and salts
  • lubricants such as, for example, talc, magnesium ste
  • a wide variety of pressure agglomeration equipment is available and may be used to agglomerate the composition. These include, for example, presses, granulators, and extruders. Preferred agglomeration equipment are those which are considered high pressure agglomerators such as, for example, pellet presses, tablet presses, and roller presses. Low to medium pressure equipment such as pan granulators or extruders can also be used. However, because they typically require the use of liquids, usually water, to form a slurry, dough, or paste prior to extrusion, uncontrollable and significant loss of the cyclopropene due to desorption from the complex may occur during processing.
  • the tablets, wafers, pellets, briquettes, and similar forms of agglomerated cyclopropene/encapsulation agent complexes may range from less 0.1 mm in size to more than 5 cm.
  • the agglomerated material is 0.5 to 2 cm in size.
  • the agglomerated material is a tablet or wafer. More preferably, the agglomerated material is a tablet.
  • compositions of this invention in which a cyclodextrin is the molecular encapsulation agent, may be prepared without additional adjuvants.
  • Other encapsulation agents may also possess such inherent binding characteristics.
  • compositions of this invention may comprise from 3 percent to 100 percent, by weight, cyclopropene/encapsulation agent complex, 0 percent to 97 percent, by weight, binder, and from 0 percent to 3 percent, by weight, lubricant.
  • the compositions of this invention comprise: 1-methylcyclopropene/a-cyclodextrin complex 25-60% Binder: 40-74% Lubricant: 1-2%
  • compositions of this invention comprise: 1-methylcyclopropene/a-cyclodextrin complex 45-55% Binder: 45-55% Lubricant: 0-2%
  • compositions of this invention comprise: 1-methylcyclopropene/a-cyclodextrin complex 50% Binder: 50% Lubricant: 0-1.5%
  • release of the cyclopropene from the cyclopropene/ ⁇ -cyclodextrin complex is accomplished by simply adding water, or other solvent, to the complex.
  • the mixture is then agitated to aid in evolution of the cyclopropene from the mixture.
  • the density achieved in the tablet was about 1.55 g/cm 3 as compared to the bulk density of about 0.50 g/cm 3 for the 1-MCP/ ⁇ -CD complex powder.
  • the bulk density of the agglomerated complex will be greater than 0.6 g/cm 3 ; more preferably, the bulk density will be from 0.75 to 2.0 g/cm 3 ; even more preferably, the bulk density will be from 1.0 to 1.75 g/cm 3 ; and most preferably, the bulk density will be from 1.4 to 1.6 g/cm 3 .
  • the 1-methylcyclopropene release characteristics of the agglomerated verses non-agglomerated complexes were determined by sealing a tablet of the agglomerated material in a bottle fitted with a septum, injecting water into the bottle, and analyzing the headspace for 1-MCP at 7 minute time intervals.
  • the analysis method was gas chromatography using the following parameters: Instrument: Hewlett Packard (Agilent Technologies) 6890 Detector: Flame Ionization Detector Temperature: 150 deg. C. Air Flow Rate: 450 ml/min. Hydrogen Flow Rate: 40 ml/min. Make up Gas Flow Rate: 25 ml/min.
  • the tablet had a significantly reduced initial release rate compared to the powder, yet the total amount released was about the same after 35-42 minutes. Even at the first point measured (equivalent to time zero), the powder had already released 6.5% of the active ingredient whereas the tablet had released less than 1%. At 7 minutes, the powder had released 43% of the active ingredient versus only 12.5% for the tablet. In addition to the release characteristics, the tablets were non-dusty compared to the powder control. TABLE 1 Time after water % 1-MCP Released % 1-MCP Released addition (min.) From Powder From Tablet 0 6.5 0.5 7 43 12.5 14 53.5 32.5 21 67.5 53.5 28 75 64 35 82.5 79 42 91.5 89.5

Abstract

The present invention relates to complexes formed from molecular encapsulation agents such as cyclodextrin, and cyclopropene and its derivatives such as methylcyclopropene, which are capable of inhibiting the ethylene response in plants, wherein the complex is pressure agglomerated.

Description

  • The present invention relates to complexes formed from molecular encapsulation agents such as cyclodextrin, and cyclopropene and its derivatives such as methylcyclopropene, which are capable of inhibiting the ethylene response in plants. Such complexes provide a convenient means for storing and transporting these compounds which are reactive gases and highly unstable because of oxidation and other potential reactions. Such complexes also provide convenient methods of delivering to plants these compounds in order to extend their shelf life. [0001]
  • It is well known that ethylene can cause the premature death of plants including flowers, leaves, fruits and vegetables through binding with certain receptors in the plant. It can also promote leaf yellowing and stunted growth as well as premature fruit, flower and leaf drop. Because of these ethylene-induced problems, very active and intense research presently concerns the investigation of ways to prevent or reduce the deleterious effects of ethylene on plants. U.S. Pat. No. 5,518,988 discloses the use of cyclopropene and its derivatives, including methylcyclopropene, as effective blocking agents for ethylene binding. However, a major problem with these compounds is that they are typically unstable gases which present explosive hazards when compressed. As a solution to these problems, U.S. Pat. No. 6,017,849 discloses a method of incorporating these gaseous compounds into a molecular encapsulation agent complex in order to stabilize their reactivity and thereby provide a convenient and safe means of storing, transporting and applying or delivering the active compounds to plants. For the most active cyclopropene derivative disclosed in U.S. Pat. No. 5,518,988, 1-methylcyclopropene, the preferred molecular encapsulation agent is a cyclodextrin with a-cyclodextrin being the most preferred. The application or delivery of these active compounds is then accomplished by simply adding water to the molecular encapsulation agent complex. The complex prepared according to the methods disclosed in U.S. Pat. No. 6,017,849 provides the material in the form of a powder. [0002]
  • Powder formulations suffer from a number of deficiencies including, for example, dustiness, difficulty in measuring small amounts (which may require that the material be prepackaged), and difficulty in controlling the release of the encapsulated material from the powder. The 1-methylcyclopropene/α-cyclodextrin complex noted above releases the 1-methylcyclopropene very quickly. It would be advantageous to moderate the release of 1-methylcyclopropene so that very little of it is released during the first few minutes after the complex is added to water. This would help prevent the escape of the 1-methylcyclopropene from the treatment area before it can be sealed and, consequently, improve the efficacy of the treatment. [0003]
  • We have discovered a modification to the encapsulation method of U.S. Pat. No. 6,017,849 which overcomes many deficiencies inherent in a free-flowing α-cyclodextrin based powder delivery system. Because 1-methylcyclopropene releases from the α-cyclodextrin complex so easily in the presence of water, water is not used in the present process to make the improved delivery system. We have found that pressure agglomeration of the 1-methylcyclopropene/α-cyclodextrin complex can be used to form tablets, wafers, pellets, briquettes, and similar forms, with or without added adjuvants. These delivery systems slow the release of 1-methylcyclopropene yet still allow its complete release. This same process may be equally applicable to other cyclopropene/molecular encapsulation agent complexes. [0004]
  • The present invention is, therefore, a composition comprising: [0005]
  • a) a cyclopropene of the formula: [0006]
    Figure US20020058592A1-20020516-C00001
  • wherein R is hydrogen or a substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, phenyl, or naphthyl group; wherein the substituents are independently halogen, alkoxy, or substituted or unsubstituted phenoxy; [0007]
  • b) a molecular encapsulation agent within which the cyclopropene is encapsulated; and [0008]
  • c) optionally one or more adjuvants; [0009]
  • wherein the composition is pressure agglomerated. [0010]
  • As used herein, the term “alkyl” means both straight and branched chain (C[0011] 1-C20) radicals which include, for example, methyl, ethyl, n-propyl, isopropyl, 1-ethylpropyl, n-butyl, tert-butyl, isobutyl, 2,2-dimethylpropyl, pentyl, octyl, and decyl. The terms “alkenyl” and “alkynyl” mean (C3-C20)alkenyl and (C3-C20)alkynyl groups such as, for example, 2-propenyl, 2-butenyl, 3-butenyl, 2-methyl-2-propenyl, and 2-propynyl. The term “cycloalkylalkyl” means a (C1-C15) alkyl group substituted with a (C3-C6) cycloalkyl group such as, for example cyclopropylmethyl, cyclopropylethyl, cyclobutylmethyl, and cyclopentylethyl. The term “haloalkyl” means an alkyl radical wherein one or more of the hydrogen atoms have been replaced by a halogen atom. The term “halogen” means fluorine, chlorine, bromine, and iodine.
  • Preferably, R is (C[0012] 1-C10) alkyl. More preferably, R is (C1-C8) alkyl. Even more preferably R is (C1-C4) alkyl. Most preferably, R is methyl.
  • Preferred encapsulating agents include cyclodextrins, crown ethers, polyoxyalkylenes, polysiloxanes, and zeolites. More preferred encapsulating agents include α-cyclodextrin, β-cyclodextrin, and γ-cyclodextrin. The most preferred encapsulating agent, particularly when the cyclopropene is 1-methylcyclopropene, is α-cyclodextrin. The most preferred encapsulting agent will vary depending upon the size of the R substituent. However, as one skilled in the art will appreciate, any cyclodextrin or mixture of cyclodextrins, cyclodextrin polymers as well as modified cyclodextrins can also be utilized pursuant to the present invention. Cyclodextrins are available from Wacker Biochem Inc., Adrian, Mich. or Cerestar USA, Hammond, Ind., as well as other vendors. [0013]
  • As used herein, all percentages are percent by weight and all parts are parts by weight, unless otherwise specified, and are inclusive and combinable. All ratios are by weight and all ratio ranges are inclusive and combinable. All molar ranges are inclusive and combinable. [0014]
  • The cyclopropenes applicable to this invention are known materials prepared using the processes disclosed in U.S. Pat. Nos. 5,518,988 and 6,017,849. The cyclopropene/molecular encapsulation agent complexes of the present invention are prepared by contacting the cyclopropene with a solution or slurry of the molecular encapsulation agent and then isolating the complex, again using general processes disclosed in U.S. Pat. No. 6,017,849. [0015]
  • It is often desirable to include in the composition of this invention one or more adjuvants, such as, for example, binders, lubricants, release agents, surfactants and/or dispersants, wetting agents, spreading agents, dispersing agents, stickers, adhesives, defoamers, thickeners, and emulsifying agents. Such adjuvants commonly used in the art can be found in the John W. McCutcheon, Inc. publication [0016] Detergents and Emulsifiers, Annual, Allured Publishing Company, Ridgewood, N.J., U.S.A. One or more of such adjuvants may be added to the composition prior to agglomeration or as a coating onto the agglomerated material. Optionally, adjuvants may be added to the composition at the time the cyclopropene is released as an aid to the releasing process. Preferred adjuvants include; a) binders such as, for example, sucrose, dextrose, dextrins, and other sugars and starches, polymers such as polyvinyl alcohol and lignosulfonates, and inorganics such as clays and salts, b) lubricants such as, for example, talc, magnesium stearate, stearic acid, graphite, and waxes, and c) release agents such as surfactants including, for example, sodium dodecyl sulfate.
  • A wide variety of pressure agglomeration equipment is available and may be used to agglomerate the composition. These include, for example, presses, granulators, and extruders. Preferred agglomeration equipment are those which are considered high pressure agglomerators such as, for example, pellet presses, tablet presses, and roller presses. Low to medium pressure equipment such as pan granulators or extruders can also be used. However, because they typically require the use of liquids, usually water, to form a slurry, dough, or paste prior to extrusion, uncontrollable and significant loss of the cyclopropene due to desorption from the complex may occur during processing. [0017]
  • Using such pressure agglomeration equipment, the tablets, wafers, pellets, briquettes, and similar forms of agglomerated cyclopropene/encapsulation agent complexes may range from less 0.1 mm in size to more than 5 cm. Preferably the agglomerated material is 0.5 to 2 cm in size. Preferably, the agglomerated material is a tablet or wafer. More preferably, the agglomerated material is a tablet. [0018]
  • Because cyclodextrins, as well as cyclopropene/cyclodextrin complexes, possess their own binding characteristics, compositions of this invention, in which a cyclodextrin is the molecular encapsulation agent, may be prepared without additional adjuvants. Other encapsulation agents may also possess such inherent binding characteristics. [0019]
  • The compositions of this invention may comprise from 3 percent to 100 percent, by weight, cyclopropene/encapsulation agent complex, 0 percent to 97 percent, by weight, binder, and from 0 percent to 3 percent, by weight, lubricant. Preferably, the compositions of this invention comprise: [0020]
    1-methylcyclopropene/a-cyclodextrin complex 25-60%
    Binder: 40-74%
    Lubricant: 1-2%
  • More preferably, the compositions of this invention comprise: [0021]
    1-methylcyclopropene/a-cyclodextrin complex 45-55%
    Binder: 45-55%
    Lubricant: 0-2%
  • Most preferably, the compositions of this invention comprise: [0022]
    1-methylcyclopropene/a-cyclodextrin complex 50%
    Binder: 50%
    Lubricant: 0-1.5%
  • In practice, release of the cyclopropene from the cyclopropene/α-cyclodextrin complex is accomplished by simply adding water, or other solvent, to the complex. Preferably, the mixture is then agitated to aid in evolution of the cyclopropene from the mixture. [0023]
  • Some embodiments of this invention are illustrated by the following example:[0024]
  • EXAMPLE Comparison of 1-Methylcyclopropene Release from Agglomerated and Non-Agglomerated Compositions
  • A dry-blend mixture of 50%, by weight, 1-methylcyclopropene/α-cyclodextrin (“1-MCP/α-CD”) complex powder prepared according to the process of U.S. Pat. No. 6,017,849 and 50%, by weight, dextrose powder was prepared and split into two aliquots. The first was kept as a control and the second was compression agglomerated in a DELTA™ tablet press (Aldrich, Milwaukee, Wis.) utilizing differential screw thread compression. The resulting tablets measured 9 mm in diameter by 1 mm in thickness and weighed 0.10 gm each. The density achieved in the tablet was about 1.55 g/cm[0025] 3 as compared to the bulk density of about 0.50 g/cm3 for the 1-MCP/α-CD complex powder. Preferably, the bulk density of the agglomerated complex will be greater than 0.6 g/cm3; more preferably, the bulk density will be from 0.75 to 2.0 g/cm3; even more preferably, the bulk density will be from 1.0 to 1.75 g/cm3; and most preferably, the bulk density will be from 1.4 to 1.6 g/cm3.
  • The 1-methylcyclopropene release characteristics of the agglomerated verses non-agglomerated complexes were determined by sealing a tablet of the agglomerated material in a bottle fitted with a septum, injecting water into the bottle, and analyzing the headspace for 1-MCP at 7 minute time intervals. The analysis method was gas chromatography using the following parameters: [0026]
    Instrument: Hewlett Packard (Agilent Technologies)
    6890
    Detector: Flame Ionization
    Detector Temperature: 150 deg. C.
    Air Flow Rate: 450 ml/min.
    Hydrogen Flow Rate: 40 ml/min.
    Make up Gas Flow Rate: 25 ml/min.
    Column: Chrompack CP-PoraPlot Q-HT
    Dimensions: 10 m × 0.32 mm i.d.
    Film Thickness: 10 microns
    Carrier Gas: Helium
    Flow Rate: 2.5 ml/min
    Column Head Pressure: 6 psi
    Injection Port Temperature: 150 deg. C.
    Initial Temperature: 35 deg. C.
    Initial Time: 0.5 min.
    Program Rate 1: 20 deg. C./min.
    Final Temperature: 250 deg. C.
    Final Time: 6.5 min.
    Injection Volume: 1 ml
    Injector: Manual/Splitless (1 ml inlet glass Liner)
  • Release of 1-methylcyclopropene from an equivalent amount of the dry blended powder control (non-agglomerated complex) was evaluated in the same manner. Table 1 shows the resulting average release profiles produced from two separate samples each of the tablet and powder delivery systems. [0027]
  • Clearly, the tablet had a significantly reduced initial release rate compared to the powder, yet the total amount released was about the same after 35-42 minutes. Even at the first point measured (equivalent to time zero), the powder had already released 6.5% of the active ingredient whereas the tablet had released less than 1%. At 7 minutes, the powder had released 43% of the active ingredient versus only 12.5% for the tablet. In addition to the release characteristics, the tablets were non-dusty compared to the powder control. [0028]
    TABLE 1
    Time after water % 1-MCP Released % 1-MCP Released
    addition (min.) From Powder From Tablet
    0 6.5 0.5
    7 43 12.5
    14 53.5 32.5
    21 67.5 53.5
    28 75 64
    35 82.5 79
    42 91.5 89.5

Claims (10)

We claim:
1. A composition comprising:
a) a cyclopropene of the formula:
Figure US20020058592A1-20020516-C00002
wherein R is hydrogen or a substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, phenyl, or naphthyl group;
wherein the substituents are independently halogen, alkoxy, or substituted or unsubstituted phenoxy;
b) a molecular encapsulation agent within which the cyclopropene is encapsulated; and
c) optionally one or more adjuvants;
wherein the composition is pressure agglomerated.
2. The composition of claim 1, wherein R is (C1-C8)alkyl.
3. The composition of claim 1, wherein R is methyl.
4. The composition of claim 1, wherein the molecular encapsulation agent is a cyclodextrin or a mixture of cyclodextrins.
5. The composition of claim 1, wherein the molecular encapsulation agent is α-cyclodextrin.
6. The composition of claim 1, wherein the optional adjuvant is:
a) a lubricant; or
b) a release agent, or
c) a mixture of a lubricant and a release agent.
7. The composition of claim 1, wherein the composition is pressure agglomerated using a tablet press.
8. A method for preparing a composition of an encapsulated cyclopropene comprising pressure agglomerating a composition comprising:
a) a cyclopropene of the formula:
Figure US20020058592A1-20020516-C00003
wherein R is hydrogen or a substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, phenyl, or naphthyl group;
wherein the substituents are independently halogen, alkoxy, or substituted or unsubstituted phenoxy;
b) a molecular encapsulation agent within which the cyclopropene is encapsulated; and
c) optionally one or more adjuvants.
9. The method of claim 8, wherein the molecular encapsulation agent is α-cyclodextrin.
10. The method of claim 8, wherein the optional adjuvant is:
a) a lubricant; or
b) a release agent, or
c) a mixture of a lubricant and a release agent.
US09/950,967 2000-09-28 2001-09-12 Delivery system for cyclopropenes Expired - Lifetime US6444619B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/950,967 US6444619B1 (en) 2000-09-28 2001-09-12 Delivery system for cyclopropenes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23608700P 2000-09-28 2000-09-28
US09/950,967 US6444619B1 (en) 2000-09-28 2001-09-12 Delivery system for cyclopropenes

Publications (2)

Publication Number Publication Date
US20020058592A1 true US20020058592A1 (en) 2002-05-16
US6444619B1 US6444619B1 (en) 2002-09-03

Family

ID=22888086

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/950,967 Expired - Lifetime US6444619B1 (en) 2000-09-28 2001-09-12 Delivery system for cyclopropenes

Country Status (15)

Country Link
US (1) US6444619B1 (en)
EP (1) EP1192859B1 (en)
JP (1) JP2002145808A (en)
KR (1) KR100864088B1 (en)
CN (1) CN1206907C (en)
AR (1) AR030754A1 (en)
AU (1) AU783226B2 (en)
BR (1) BR0104287A (en)
CA (1) CA2357894C (en)
DE (1) DE60100313T2 (en)
ES (1) ES2199917T3 (en)
IL (1) IL145477A (en)
MX (1) MXPA01009757A (en)
NZ (1) NZ514235A (en)
TW (1) TWI265783B (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770600B1 (en) 2003-02-28 2004-08-03 Rohm And Haas Company Delivery systems for cyclopropene compounds
US20060122624A1 (en) * 2004-12-06 2006-06-08 Csaba Truckai Bone treatment systems and methods
US20110143004A1 (en) * 2009-12-14 2011-06-16 Cellresin Technologies, Llc Maturation or ripening inhibitor release from polymer, fiber, film, sheet or packaging
EP2401917A3 (en) * 2010-07-02 2012-05-30 Rohm and Haas Company Coated powder particles
GB2491424A (en) * 2011-03-27 2012-12-05 Cellresin Tech Llc Cyclodextrin compositions, articles and methods
WO2014085518A1 (en) * 2012-11-30 2014-06-05 Kimberly-Clark Worldwide, Inc. Controlled release compositions and methods of using
US9421793B2 (en) 2014-06-26 2016-08-23 Cellresin Technologies, Llc Electrostatic printing of cyclodextrin compositions
AU2014227556B2 (en) * 2012-11-30 2016-09-15 Kimberly-Clark Worldwide, Inc. Controlled Release Compositions and Methods of Using
WO2023288294A1 (en) 2021-07-16 2023-01-19 Novozymes A/S Compositions and methods for improving the rainfastness of proteins on plant surfaces
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762153B2 (en) * 2001-10-18 2004-07-13 Rohm And Haas Company Delivery system for cyclopropenes
MXPA03001082A (en) * 2002-02-27 2004-12-06 Rohm & Haas Delivery systems for cyclopropene compounds.
JP4415140B2 (en) * 2003-03-31 2010-02-17 独立行政法人農業・食品産業技術総合研究機構 Efficient treatment technology of 1-substituted-cyclopropene
CA2504840C (en) * 2004-05-05 2008-03-18 Rohm And Haas Company Humidity activated delivery systems for cyclopropenes
US20090088323A1 (en) * 2004-05-19 2009-04-02 Basel Richard M Compositions with cyclopropenes and adjuvants
TW200603731A (en) * 2004-05-19 2006-02-01 Rohm & Haas Compositions with cyclopropenes and metal-complexing agents
TW200538037A (en) * 2004-05-19 2005-12-01 Rohm & Haas Compositions with cyclopropenes and adjuvants
AU2005242218A1 (en) * 2005-01-14 2006-08-03 Rohm And Haas Company Plant growth regulation
CN100364394C (en) * 2005-08-05 2008-01-30 高荣涛 Microcapsuled fruit, vegetable and flower antistaling agent and preparation thereof
AU2006233187A1 (en) * 2005-11-08 2007-05-24 Rohm And Haas Company Compositions with cyclopropenes and non-hydrocarbon oils
KR100823872B1 (en) * 2005-11-18 2008-04-21 유상구 Cyclopropenes-generating Devices to Control Ripening Processes of Agricultural Products
US20070117720A1 (en) * 2005-11-18 2007-05-24 Jacobson Richard M Compositions with cyclopropenes
CN100340172C (en) * 2006-04-17 2007-10-03 西安交通大学 Prepn. of 1-methyl cyclopropene stable inclusion compound for fresh keeping of fruits and vegetables
PT2109641T (en) * 2007-01-17 2017-05-25 Agrofresh Inc Delivery of ethylene blocking and/or promoting agents
MX2008002145A (en) * 2007-02-22 2009-02-25 Rohm & Haas Method of making a complex.
US9012515B2 (en) * 2007-08-03 2015-04-21 Rohm And Haas Company Oil formulations with thickeners
JP5097069B2 (en) * 2007-11-06 2012-12-12 ローム アンド ハース カンパニー Method for producing inclusion complex
KR101605677B1 (en) * 2008-09-25 2016-03-25 (주)이룸바이오테크놀러지 Method of Preparing 1-Methylcyclopropene and Appling the Same to Plants
RU2424660C1 (en) * 2010-03-25 2011-07-27 Валерий Федорович Швец Composition for treating plants and fruits and methods of increasing yield of horticultural and plant products and increasing storage life thereof
KR101429554B1 (en) 2010-04-22 2014-08-14 (주)이룸바이오테크놀러지 Cyclopropenes and Method for Applying Cyclopropenes to Agricultural Products or Crops
US10182567B2 (en) 2011-03-27 2019-01-22 Cellresin Technologies, Llc Cyclodextrin compositions, articles, and methods
CA2770949C (en) * 2011-04-05 2013-06-18 Rohm And Haas Company Controlled release compositions
US9320288B2 (en) 2012-11-30 2016-04-26 Cellresin Technologies, Llc Controlled release compositions and methods of using
PT2945482T (en) 2013-01-15 2019-05-30 Agrofresh Inc Compositions and methods for stabilizing 1-methylcyclopropene in solutions
TW201534217A (en) * 2013-07-11 2015-09-16 Agrofresh Inc Methods and compositions of granule formulations
US9394216B2 (en) 2014-11-10 2016-07-19 Mirtech, Inc. Complexes of 1-methylcyclopropene with metal coordination polymer networks
IL292557A (en) 2016-02-19 2022-06-01 Hazel Tech Inc Compositions for controlled release of active ingredients and methods of making same
RU2667512C1 (en) * 2017-07-19 2018-09-21 Елена Александровна Зиновьева Method of obtaining a preparation for processing fruits and vegetables
RU2667514C1 (en) * 2017-07-19 2018-09-21 Елена Александровна Зиновьева Method of obtaining a preparation for processing fruits and vegetables
RU2667518C1 (en) * 2017-07-19 2018-09-21 Елена Александровна Зиновьева Method of processing the harvest of fruits, berries, vegetables and greens before laying for storage
RU2667511C1 (en) * 2017-07-19 2018-09-21 Елена Александровна Зиновьева Process for the preparation of 1-methylcyclopropene
WO2019207146A1 (en) 2018-04-27 2019-10-31 Fresh Inset S.A. Compositions and articles comprising complexes of 1-methylcycloproprene and alpha-cyclodextrin
US11033870B1 (en) * 2019-11-16 2021-06-15 Nazir Mir Generators for 1-methylcyclopropene release from carrier complex
US11306046B2 (en) * 2019-11-16 2022-04-19 Nazir Mir Generators for 1-methylcyclopropene release from carrier complex
BR112022015315A2 (en) 2020-02-03 2022-09-27 Fresh Inset S A STABLE COMPOSITIONS OF 1-METHYLCYLOPROPENE AND USES THEREOF
US20210331990A1 (en) 2020-04-27 2021-10-28 Cellresin Technologies, Llc Compositions and Methods for Differential Release of 1-Methylcyclopropene

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277610A (en) 1985-06-03 1986-12-08 Kao Corp Bathing agent
CA1321192C (en) * 1988-04-20 1993-08-10 Abdul Majid Inclusion complexes of cyclodextrins by agglomeration
JP3052364B2 (en) * 1989-12-19 2000-06-12 栗田工業株式会社 Host compounds and clathrates
JP3175252B2 (en) * 1991-12-12 2001-06-11 日本曹達株式会社 New clathrate compound
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
JPH0853304A (en) * 1994-05-18 1996-02-27 Nippon Soda Co Ltd Molded product of clathrated compound
US5518988A (en) * 1994-06-03 1996-05-21 North Carolina State University Method of counteracting an ethylene response in plants
US6017849A (en) * 1998-08-20 2000-01-25 Biotechnologies For Horticulture, Inc. Synthesis methods, complexes and delivery methods for the safe and convenient storage, transport and application of compounds for inhibiting the ethylene response in plants

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770600B1 (en) 2003-02-28 2004-08-03 Rohm And Haas Company Delivery systems for cyclopropene compounds
US20060122624A1 (en) * 2004-12-06 2006-06-08 Csaba Truckai Bone treatment systems and methods
US9642356B2 (en) 2009-12-14 2017-05-09 Cellresin Technologies, Llc Maturation or ripening inhibitor release from polymer, fiber, film, sheet or packaging
US20110143004A1 (en) * 2009-12-14 2011-06-16 Cellresin Technologies, Llc Maturation or ripening inhibitor release from polymer, fiber, film, sheet or packaging
EP2401917A3 (en) * 2010-07-02 2012-05-30 Rohm and Haas Company Coated powder particles
GB2491424A (en) * 2011-03-27 2012-12-05 Cellresin Tech Llc Cyclodextrin compositions, articles and methods
US8414989B2 (en) 2011-03-27 2013-04-09 Cellresin Technologies, Llc Cyclodextrin compositions, articles, and methods
GB2491424B (en) * 2011-03-27 2013-04-17 Cellresin Tech Llc Cyclodextrin compositions, articles and methods
US8481127B2 (en) 2011-03-27 2013-07-09 Cellresin Technologies, Llc Cyclodextrin compositions, articles, and methods
WO2014085518A1 (en) * 2012-11-30 2014-06-05 Kimberly-Clark Worldwide, Inc. Controlled release compositions and methods of using
RU2591453C1 (en) * 2012-11-30 2016-07-20 Кимберли - Кларк Ворлдвайд, Инк. Controlled release composition and methods of application
AU2014227556B2 (en) * 2012-11-30 2016-09-15 Kimberly-Clark Worldwide, Inc. Controlled Release Compositions and Methods of Using
CN104936447A (en) * 2012-11-30 2015-09-23 赛尔瑞星技术有限公司 Controlled release compositions and methods of using
CN104936447B (en) * 2012-11-30 2018-03-06 塞尔瑞星技术有限公司 Control release composition and application method
US9421793B2 (en) 2014-06-26 2016-08-23 Cellresin Technologies, Llc Electrostatic printing of cyclodextrin compositions
US10376472B2 (en) 2014-06-26 2019-08-13 Cellresin Technologies, Llc Electrostatic printing of cyclodextrin compositions
WO2023288294A1 (en) 2021-07-16 2023-01-19 Novozymes A/S Compositions and methods for improving the rainfastness of proteins on plant surfaces
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Also Published As

Publication number Publication date
DE60100313T2 (en) 2004-02-12
IL145477A (en) 2006-07-05
KR100864088B1 (en) 2008-10-16
AU7214101A (en) 2002-04-11
EP1192859B1 (en) 2003-05-28
AR030754A1 (en) 2003-09-03
CN1206907C (en) 2005-06-22
BR0104287A (en) 2002-06-04
CN1349733A (en) 2002-05-22
CA2357894A1 (en) 2002-03-28
CA2357894C (en) 2006-05-23
NZ514235A (en) 2002-07-26
IL145477A0 (en) 2002-06-30
MXPA01009757A (en) 2002-04-15
ES2199917T3 (en) 2004-03-01
AU783226B2 (en) 2005-10-06
JP2002145808A (en) 2002-05-22
US6444619B1 (en) 2002-09-03
TWI265783B (en) 2006-11-11
KR20020025716A (en) 2002-04-04
DE60100313D1 (en) 2003-07-03
EP1192859A1 (en) 2002-04-03

Similar Documents

Publication Publication Date Title
US6444619B1 (en) Delivery system for cyclopropenes
US6762153B2 (en) Delivery system for cyclopropenes
US6426319B1 (en) Delivery systems for cyclopropenes requiring less water
EP1593306B1 (en) Humidity activated delivery systems for cyclopropenes
EP1597967B1 (en) Compositions with cyclopropenes and metal-complexing agents
JP2002523337A (en) Plant ethylene response inhibiting compounds and complexes
CA2512254C (en) Compositions with cyclopropenes and metal-complexing agents

Legal Events

Date Code Title Description
AS Assignment

Owner name: ROHM AND HAAS COMPANY, PENNSYLVANIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KOSTANSEK, EDWARD CHARLES;REEL/FRAME:013083/0334

Effective date: 20001218

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: AGROFRESH INC, PENNSYLVANIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ROHM AND HAAS COMPANY;DOW GLOBAL TECHNOLOGIES LLC;DOW AGROSCIENCES LLC;REEL/FRAME:035932/0335

Effective date: 20150610

AS Assignment

Owner name: BANK OF MONTREAL, AS ADMINISTRATIVE AGENT, NEW YOR

Free format text: SECURITY INTEREST;ASSIGNOR:AGROFRESH INC.;REEL/FRAME:036243/0244

Effective date: 20150730

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

AS Assignment

Owner name: BANK OF MONTREAL, AS COLLATERAL AGENT, ILLINOIS

Free format text: PATENT SECURITY AGREEMENT;ASSIGNOR:AGROFRESH, INC.;REEL/FRAME:053316/0561

Effective date: 20200727

AS Assignment

Owner name: AGROFRESH, INC., PENNSYLVANIA

Free format text: TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 053316, FRAME 0561;ASSIGNOR:BANK OF MONTREAL;REEL/FRAME:063238/0901

Effective date: 20230331

Owner name: AGROFRESH, INC., PENNSYLVANIA

Free format text: TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 036243, FRAME 0244;ASSIGNOR:BANK OF MONTREAL;REEL/FRAME:063238/0848

Effective date: 20230331